CAPTRUST Financial Advisors’s Castle Biosciences CSTL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-215,322
| Closed | -$5.74M | – | 2379 |
|
2024
Q4 | $5.74M | Buy |
215,322
+207,250
| +2,568% | +$5.52M | 0.02% | 502 |
|
2024
Q3 | $230K | Sell |
8,072
-13,053
| -62% | -$372K | ﹤0.01% | 2050 |
|
2024
Q2 | $460K | Buy |
21,125
+75
| +0.4% | +$1.63K | ﹤0.01% | 1550 |
|
2024
Q1 | $466K | Sell |
21,050
-17,359
| -45% | -$385K | ﹤0.01% | 1520 |
|
2023
Q4 | $829K | Sell |
38,409
-324
| -0.8% | -$6.99K | ﹤0.01% | 1387 |
|
2023
Q3 | $654K | Sell |
38,733
-190,958
| -83% | -$3.23M | ﹤0.01% | 1468 |
|
2023
Q2 | $3.15M | Buy |
229,691
+60,959
| +36% | +$836K | 0.01% | 659 |
|
2023
Q1 | $3.83M | Buy |
+168,732
| New | +$3.83M | 0.02% | 536 |
|
2022
Q3 | – | Sell |
-497
| Closed | -$11K | – | 2491 |
|
2022
Q2 | $11K | Buy |
497
+31
| +7% | +$686 | ﹤0.01% | 3688 |
|
2022
Q1 | $21K | Buy |
466
+34
| +8% | +$1.53K | ﹤0.01% | 3347 |
|
2021
Q4 | $19K | Sell |
432
-67
| -13% | -$2.95K | ﹤0.01% | 3302 |
|
2021
Q3 | $33K | Buy |
499
+65
| +15% | +$4.3K | ﹤0.01% | 2842 |
|
2021
Q2 | $32K | Buy |
434
+389
| +864% | +$28.7K | ﹤0.01% | 2794 |
|
2021
Q1 | $3K | Buy |
+45
| New | +$3K | ﹤0.01% | 3899 |
|